HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1801	14666 Tolnay M, Clavaguera F Argyrophilic grain disease: A late-onset dementia with distinctive features among tauopathies NEUROPATHOLOGY. 2004 DEC; 24 (4): 269-283	25	36	33	101
1802	14699 Lo Bianco C, Schneider BL, Bauer M, Sajadi A, Brice A, et al. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004 DEC 14; 101 (50): 17510-17515	58	97	33	47
1803	14706 Kalia SK, Lee S, Smith PD, Liu L, Crocker SJ, et al. BAG5 inhibits parkin and enhances dopaminergic neuron degeneration NEURON. 2004 DEC 16; 44 (6): 931-945	24	60	33	67
1804	14794 Katsel PL, Davis KL, Haroutunian V Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 63. 2005; 63: 41-82	13	26	33	228
1805	14931 Muchowski PJ, Wacker JL Modulation of neurodegeneration by molecular chaperones NATURE REVIEWS NEUROSCIENCE. 2005 JAN; 6 (1): 11-22	105	318	33	124
1806	14999 Liu F, Iqbal K, Grundke-Iqbal I, Rossie S, Gong CX Dephosphorylation of tau by protein phosphatase 5 - Impairment in Alzheimer's disease JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 JAN 21; 280 (3): 1790-1796	12	22	33	57
1807	15096 Halverson RA, Lewis J, Frausto S, Hutton M, Muma NA Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice JOURNAL OF NEUROSCIENCE. 2005 FEB 2; 25 (5): 1226-1233	7	11	33	46
1808	15099 Pickhardt M, Gazova Z, von Bergen M, Khlistunova I, Wang YP, et al. Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 FEB 4; 280 (5): 3628-3635	61	89	33	56
1809	15117 Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, et al. P25 alpha stimulates a-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 FEB 18; 280 (7): 5703-5715	24	43	33	48
1810	15423 Mott RT, Dickson DW, Trojanowski JQ, Zhukareva V, Lee VMY, et al. Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 MAY; 64 (5): 420-428	53	53	33	55
#	Date / Author / Journal	LCS	GCS	LCR	CR
1811	15459 Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, et al. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease NEUROLOGY. 2005 MAY 10; 64 (9): 1578-1585	20	20	33	43
1812	15724 Newman J, Rissman RA, Sarsoza F, Kim RC, Dick M, et al. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology ACTA NEUROPATHOLOGICA. 2005 AUG; 110 (2): 135-144	16	24	33	53
1813	16663 Borlongan CV, Fournier C, Stahl CE, Yu GL, Xu L, et al. Gene therapy, cell transplantation and stroke FRONTIERS IN BIOSCIENCE. 2006 JAN 1; 11: 1090-U46	2	6	33	79
1814	16666 Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, et al. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death JOURNAL OF NEUROSCIENCE. 2006 JAN 4; 26 (1): 41-50	77	128	33	56
1815	17210 Balaraman Y, Limaye AR, Levey AI, Srinivasan S Glycogen synthase kinase 3 beta and Alzheimer's disease: pathophysiological and therapeutic significance CELLULAR AND MOLECULAR LIFE SCIENCES. 2006 JUN; 63 (11): 1226-1235	8	42	33	115
1816	17421 Ding HP, Matthews TA, Johnson GVW Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 JUL 14; 281 (28): 19107-19114	14	21	33	41
1817	17821 Kontopoulos E, Parvin JD, Feany MB alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity HUMAN MOLECULAR GENETICS. 2006 OCT 15; 15 (20): 3012-3023	43	67	33	59
1818	17879 Le Ber I, Guedj E, Gabelle A, Verpillat P, Volteau M, et al. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia BRAIN. 2006 NOV; 129: 3051-3065	13	24	33	94
1819	18042 Takahashi M, Uchikado H, Caprotti D, Weidenheim KM, Dickson DW, et al. Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2006 DEC; 65 (12): 1157-1169	3	5	33	58
1820	18165 Borsello T, Forloni G JNK signalling: A possible target to prevent neurodegeneration CURRENT PHARMACEUTICAL DESIGN. 2007; 13 (18): 1875-1886	4	62	33	120
#	Date / Author / Journal	LCS	GCS	LCR	CR
1821	18480 Yasuda T, Miyachi S, Kitagawa R, Wada K, Nihira T, et al. Neuronal specificity of alpha-synuclein toxicity and effect of parkin co-expression in primates NEUROSCIENCE. 2007 JAN 19; 144 (2): 743-753	10	17	33	40
1822	18745 Schneider BL, Seehus CR, Capowski EE, Aebischer P, Zhang C, et al. Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation HUMAN MOLECULAR GENETICS. 2007 MAR 15; 16 (6): 651-666	14	22	33	59
1823	19669 Holm IE, Englund E, Mackenzie IRA, Johannsen P, Isaacs AM A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3 JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2007 OCT; 66 (10): 884-891	42	46	33	66
1824	19915 Liu F, Li B, Tung EJ, Grundke-Iqbal I, Iqbal K, et al. Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation EUROPEAN JOURNAL OF NEUROSCIENCE. 2007 DEC; 26 (12): 3429-3436	14	20	33	46
1825	19921 Winklhofer KF The parkin protein as a therapeutic target in Parkinson's disease EXPERT OPINION ON THERAPEUTIC TARGETS. 2007 DEC; 11 (12): 1543-1552	2	4	33	85
1826	19996 Kimura T, Yamashita S, Fukuda T, Park JM, Murayama M, et al. Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau EMBO JOURNAL. 2007 DEC 12; 26 (24): 5143-5152	8	19	33	57
1827	20084 Mukaetova-Ladinska EB, Milne J, Andras A, Abdel-All Z, Cerejeira J, et al. Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2008; 26 (1): 32-42	5	6	33	52
1828	20371 Sandal M, Valle F, Tessari I, Mammi S, Bergantino E, et al. Conformational equilibria in monomeric alpha-synuclein at the single- molecule level PLOS BIOLOGY. 2008 JAN; 6 (1): Art. No. e6	0	34	33	70
1829	20653 Soper JH, Roy S, Stieber A, Lee E, Wilson RB, et al. alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae MOLECULAR BIOLOGY OF THE CELL. 2008 MAR; 19 (3): 1093-1103	19	19	33	59
1830	20829 Wakamatsu M, Ishii A, Iwata S, Sakagami J, Ukai Y, et al. Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice NEUROBIOLOGY OF AGING. 2008 APR; 29 (4): 574-585	20	22	33	46
#	Date / Author / Journal	LCS	GCS	LCR	CR
1831	20942 Richter-Landsberg C The cytoskeleton in oligodendrocytes JOURNAL OF MOLECULAR NEUROSCIENCE. 2008 MAY; 35 (1): 55-63	2	16	33	80
1832	20971 Klegeris A, Pelech S, Giasson BI, Maguire J, Zhang H, et al. alpha-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia NEUROBIOLOGY OF AGING. 2008 MAY; 29 (5): 739-752	21	27	33	83
1833	21034 Chen-Plotkin AS, Geser F, Plotkin JB, Clark CM, Kwong LK, et al. Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration HUMAN MOLECULAR GENETICS. 2008 MAY 15; 17 (10): 1349-1362	15	15	33	64
1834	21479 Liu F, Hindupur J, Nguyen JL, Ruf KJ, Zhu J, et al. Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults FREE RADICAL BIOLOGY AND MEDICINE. 2008 AUG 1; 45 (3): 242-255	4	11	33	57
1835	21733 Brundin P, Li JY, Holton JL, Lindvall O, Revesz T Research in motion: the enigma of Parkinson's disease pathology spread NATURE REVIEWS NEUROSCIENCE. 2008 OCT; 9 (10): 741-745	29	45	33	58
1836	21756 Caudle WM, Pan S, Shi M, Quinn T, Hoekstra J, et al. Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease PROTEOMICS CLINICAL APPLICATIONS. 2008 OCT; 2 (10-11): 1484-1497	2	5	33	122
1837	21785 Ittner LM, Fath T, Ke YD, Bi M, van Eersel J, et al. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008 OCT 14; 105 (41): 15997-16002	20	25	33	47
1838	22178 Watson R, Blamire AM, O'Brien JT Magnetic Resonance Imaging in Lewy Body Dementias DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2009; 28 (6): 493-506	3	4	33	72
1839	22220 Morcos M, Hutter H The Model Caenorhabditis elegans in Diabetes Mellitus and Alzheimer's Disease JOURNAL OF ALZHEIMERS DISEASE. 2009; 16 (4): 897-908	4	6	33	142
1840	22660 Lambert MP, Velasco PT, Viola KL, Klein WL Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid beta-Derived Neurotoxins CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2009 MAR; 8 (1): 65-81	5	5	33	122
#	Date / Author / Journal	LCS	GCS	LCR	CR
1841	22687 Yu Y, Run XQ, Liang ZH, Li Y, Liu F, et al. Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (6): 1480-1494	3	7	33	67
1842	22996 Diehl-Schmid J, Neumann M, Laws SM, Perneczky R, Grimmer T, et al. Frontotemporal Lobar Degeneration Part 2: Neuroimaging, Neuropathology, Neurogenetics FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE. 2009 MAY; 77 (5): 295-301	1	2	33	51
1843	23192 Saiki S, Hattori N Molecular Genetics and Pathogenesis of Parkinson Disease NEUROLOGICAL SURGERY. 2009 JUN; 37 (6): 531-541	0	0	33	83
1844	23289 Liu F, Shi JH, Tanimukai H, Gu JH, Gu JL, et al. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease BRAIN. 2009 JUL; 132: 1820-1832	9	22	33	67
1845	23429 Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, et al. TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 JUL 24; 284 (30): 20329-20339	31	37	33	46
1846	23489 Planel E, Bretteville A, Liu L, Virag L, Du AL, et al. Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia FASEB JOURNAL. 2009 AUG; 23 (8): 2595-2604	6	15	33	52
1847	23730 Lendel C, Bertoncini CW, Cremades N, Waudby CA, Vendruscolo M, et al. On the Mechanism of Nonspecific Inhibitors of Protein Aggregation: Dissecting the Interactions of alpha-Synuclein with Congo Red and Lacmoid BIOCHEMISTRY. 2009 SEP 8; 48 (35): 8322-8334	2	8	33	60
1848	23844 Shah SB, Nolan R, Davis E, Stokin GB, Niesman I, et al. Examination of potential mechanisms of amyloid-induced defects in neuronal transport NEUROBIOLOGY OF DISEASE. 2009 OCT; 36 (1): 11-25	3	5	33	111
1849	23906 Uno Y, Iwashita H, Tsukamoto T, Uchiyama N, Kawamoto T, et al. Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3- (1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3- carboxamide in tau transgenic mice BRAIN RESEARCH. 2009 OCT 16; 1296: 148-163	0	1	33	45
1850	23907 Moisse K, Mepham J, Volkening K, Welch I, Hill T, et al. Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL-/- mice: Support for a role for TDP-43 in the physiological response to neuronal injury BRAIN RESEARCH. 2009 OCT 16; 1296: 176-186	11	11	33	52
#	Date / Author / Journal	LCS	GCS	LCR	CR
1851	23911 Karpinar DP, Balija MBG, Kugler S, Opazo F, Rezaei-Ghaleh N, et al. Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models EMBO JOURNAL. 2009 OCT 21; 28 (20): 3256-3268	13	23	33	52
1852	23923 Vickers JC, King AE, Woodhouse A, Kirkcaldie MT, Staal JA, et al. Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 217-223	1	6	33	105
1853	23938 Munoz DG, Neumann M, Kusaka H, Yokota O, Ishihara K, et al. FUS pathology in basophilic inclusion body disease ACTA NEUROPATHOLOGICA. 2009 NOV; 118 (5): 617-627	23	27	33	66
1854	23968 Phillips RJ, Walter GC, Ringer BE, Higgs KM, Powley TL Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat EXPERIMENTAL NEUROLOGY. 2009 NOV; 220 (1): 109-119	3	3	33	71
1855	24147 Schlachetzki JCM, Schmidtke K, Beckervordersandforth J, Borozdin W, Wilhelm C, et al. Frequency of progranulin mutations in a German cohort of 79 frontotemporal dementia patients JOURNAL OF NEUROLOGY. 2009 DEC; 256 (12): 2043-2051	0	1	33	43
1856	24464 Fahn S Parkinson's Disease: 10 Years of Progress, 1997-2007 MOVEMENT DISORDERS. 2010; 25 (3): S2-S14	0	0	33	145
1857	24724 Drzezga A Amyloid-plaque imaging in early and differential diagnosis of dementia ANNALS OF NUCLEAR MEDICINE. 2010 FEB; 24 (2): 55-66	0	0	33	91
1858	24728 Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, et al. The Spectrum of Mutations in Progranulin A Collaborative Study Screening 545 Cases of Neurodegeneration ARCHIVES OF NEUROLOGY. 2010 FEB; 67 (2): 161-170	8	8	33	54
1859	24800 Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, et al. Phosphorylation of Tau at S422 is enhanced by A beta in TauPS2APP triple transgenic mice NEUROBIOLOGY OF DISEASE. 2010 FEB; 37 (2): 294-306	4	4	33	63
1860	24842 Yang ML, Hasadsri L, Woods WS, George JM Dynamic transport and localization of alpha-synuclein in primary hippocampal neurons MOLECULAR NEURODEGENERATION. 2010 FEB 9; 5: Art. No. 9	0	0	33	45
#	Date / Author / Journal	LCS	GCS	LCR	CR
1861	24871 Latawiec D, Herrera F, Bek A, Losasso V, Candotti M, et al. Modulation of Alpha-Synuclein Aggregation by Dopamine Analogs PLOS ONE. 2010 FEB 16; 5 (2): Art. No. e9234	0	0	33	47
1862	24882 Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010 FEB 23; 107 (8): 3858-3863	34	35	33	47
1863	25153 Lauterbach EC, Shillcutt SD, Victoroff J, Coburn KL, Mendez MF Psychopharmacological Neuroprotection in Neurodegenerative Disease: Heuristic Clinical Applications JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2010 SPR; 22 (2): 130-154	0	0	33	467
1864	25388 Iijima-Ando K, Zhao LJ, Gatt A, Shenton C, Iijima K A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration HUMAN MOLECULAR GENETICS. 2010 MAY 15; 19 (10): 1930-1938	1	1	33	68
1865	25492 Eckert A, Schulz KL, Rhein V, Gotz J Convergence of Amyloid-beta and Tau Pathologies on Mitochondria In Vivo MOLECULAR NEUROBIOLOGY. 2010 JUN; 41 (2-3): 107-114	0	1	33	72
1866	25577 Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, et al. Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy ACTA NEUROPATHOLOGICA. 2010 JUL; 120 (1): 55-66	1	1	33	44
1867	25613 Schmidt AL, Brunetto AL, Schwartsmann G, Roesler R, Abujamra AL Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 335-348	0	0	33	179
1868	25674 Khurana V, Elson-Schwab I, Fulga TA, Sharp KA, Loewen CA, et al. Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo PLOS GENETICS. 2010 JUL; 6 (7): Art. No. e1001026	0	0	33	65
1869	25759 Brion JP, Ando K, Heraud C, Leroy K Modulation of tau pathology in tau transgenic models BIOCHEMICAL SOCIETY TRANSACTIONS. 2010 AUG; 38: 996-1000	0	1	33	48
1870	26390 Kleinberger G, Wils H, Ponsaerts P, Joris G, Timmermans JP, et al. Increased caspase activation and decreased TDP-43 solubility in progranulin knockout cortical cultures JOURNAL OF NEUROCHEMISTRY. 2010 NOV; 115 (3): 735-747	0	0	33	53
#	Date / Author / Journal	LCS	GCS	LCR	CR
1871	26395 Hellewell SC, Yan EB, Agyapomaa DA, Bye N, Morganti-Kossmann MC Post-Traumatic Hypoxia Exacerbates Brain Tissue Damage: Analysis of Axonal Injury and Glial Responses JOURNAL OF NEUROTRAUMA. 2010 NOV; 27 (11): 1997-2010	0	0	33	102
1872	26682 Forlenza OV, Diniz BS, Gattaz WF Diagnosis and biomarkers of predementia in Alzheimer's disease BMC MEDICINE. 2010 DEC 22; 8: Art. No. 89	0	0	33	113
1873	26692 Yang CX, Tan WJ, Whittle C, Qiu LH, Cao LC, et al. The C-Terminal TDP-43 Fragments Have a High Aggregation Propensity and Harm Neurons by a Dominant-Negative Mechanism PLOS ONE. 2010 DEC 31; 5 (12): Art. No. e15878	0	0	33	52
1874	26710 Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis ACTA NEUROPATHOLOGICA. 2011 JAN; 121 (1): 21-37	0	1	33	167
1875	26868 Scales TME, Derkinderen P, Leung KY, Byers HL, Ward MA, et al. Tyrosine Phosphorylation of Tau by the Src Family Kinases Lck and Fyn MOLECULAR NEURODEGENERATION. 2011 JAN 26; 6: Art. No. 12	0	0	33	55
1876	26909 Armstrong RA, Cairns NJ A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation HISTOLOGY AND HISTOPATHOLOGY. 2011 FEB; 26 (2): 185-190	0	0	33	44
1877	1837 YETERIAN EH, PANDYA DN CORTICOTHALAMIC CONNECTIONS OF THE SUPERIOR TEMPORAL SULCUS IN RHESUS- MONKEYS EXPERIMENTAL BRAIN RESEARCH. 1991; 83 (2): 268-284	11	28	32	120
1878	3322 GOEDERT M, JAKES R, CROWTHER RA, COHEN P, VANMECHELEN E, et al. EPITOPE MAPPING OF MONOCLONAL-ANTIBODIES TO THE PAIRED HELICAL FILAMENTS OF ALZHEIMERS-DISEASE - IDENTIFICATION OF PHOSPHORYLATION SITES IN TAU-PROTEIN BIOCHEMICAL JOURNAL. 1994 AUG 1; 301: 871-877	188	224	32	51
1879	3613 SONG JS, YANG SD TAU-PROTEIN KINASE-I GSK-3-BETA KINASE F-A IN HEPARIN PHOSPHORYLATES TAU ON SER(199), THR(231), SER(235), SER(262) SER(369), AND SER(400) SITES PHOSPHORYLATED IN ALZHEIMER-DISEASE BRAIN JOURNAL OF PROTEIN CHEMISTRY. 1995 FEB; 14 (2): 95-105	27	40	32	72
1880	3732 GOTZ J, PROBST A, SPILLANTINI MG, SCHAFER T, JAKES R, et al. SOMATODENDRITIC LOCALIZATION AND HYPERPHOSPHORYLATION OF TAU-PROTEIN IN TRANSGENIC MICE EXPRESSING THE LONGEST HUMAN BRAIN TAU-ISOFORM EMBO JOURNAL. 1995 APR 3; 14 (7): 1304-1313	160	183	32	54
#	Date / Author / Journal	LCS	GCS	LCR	CR
1881	3814 LATIMER DA, GALLO JM, LOVESTONE S, MILLER CCJ, REYNOLDS CH, et al. STIMULATION OF MAP KINASE BY V-RAF TRANSFORMATION OF FIBROBLASTS FAILS TO INDUCE HYPERPHOSPHORYLATION OF TRANSFECTED TAU FEBS LETTERS. 1995 MAY 22; 365 (1): 42-46	37	47	32	46
1882	4083 MukaetovaLadinska EB, Roth M Alzheimer's disease - New approaches to old problems INTERNATIONAL REVIEW OF PSYCHIATRY. 1995 DEC; 7 (3-4): 419-435	0	0	32	156
1883	4783 Shin RW Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease GERONTOLOGY. 1997; 43: 16-23	5	9	32	60
1884	5158 Reynolds CH, Nebreda AR, Gibb GM, Utton MA, Anderton BH Reactivating kinase/p38 phosphorylates tau protein in vitro JOURNAL OF NEUROCHEMISTRY. 1997 JUL; 69 (1): 191-198	49	94	32	69
1885	5539 Giasson BI, Mushynski WE Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit JOURNAL OF NEUROSCIENCE. 1997 DEC 15; 17 (24): 9466-9472	28	70	32	85
1886	6614 Goedert M, Crowther RA, Jakes R, Hasegawa M, Smith MJ, et al. Filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 245-258	1	2	32	42
1887	7136 Matsumura N, Yamazaki T, Ihara Y Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17) AMERICAN JOURNAL OF PATHOLOGY. 1999 JUN; 154 (6): 1649-1656	48	49	32	48
1888	7475 Dickson DW, Lin WL, Liu WK, Yen SH Multiple system atrophy: A sporadic synucleinopathy BRAIN PATHOLOGY. 1999 OCT; 9 (4): 721-732	65	91	32	84
1889	7593 Lippa CF Familial Alzheimer's disease: Genetic influences on the disease process (Review) INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 1999 NOV; 4 (5): 529-536	2	14	32	106
1890	8230 Alexi T, Borlongan CV, Faull RLM, Williams CE, Clark RG, et al. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases PROGRESS IN NEUROBIOLOGY. 2000 APR; 60 (5): 409-470	20	140	32	724
#	Date / Author / Journal	LCS	GCS	LCR	CR
1891	8583 Evans DB, Rank KB, Bhattacharya K, Thomsen DR, Gurney ME, et al. Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly JOURNAL OF BIOLOGICAL CHEMISTRY. 2000 AUG 11; 275 (32): 24977-24983	23	36	32	58
1892	9405 Lee FJS, Liu F, Pristupa ZB, Niznik HB Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis FASEB JOURNAL. 2001 APR; 15 (6): 916-926	133	200	32	84
1893	9757 McNaught KSP, Olanow CW, Halliwell B, Isacson O, Jenner P Failure of the ubiquitin-proteasome system in Parkinson's disease NATURE REVIEWS NEUROSCIENCE. 2001 AUG; 2 (8): 589-594	110	237	32	66
1894	9790 Wirdefeldt K, Bogdanovic N, Westerberg L, Payami H, Schalling M, et al. Expression of alpha-synuclein in the human brain: relation to Lewy body disease MOLECULAR BRAIN RESEARCH. 2001 AUG 15; 92 (1-2): 58-65	10	10	32	44
1895	9874 Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, et al. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease BRAIN RESEARCH. 2001 SEP 28; 914 (1-2): 48-56	78	78	32	55
1896	9907 Armstrong RJE, Jain M, Barker RA Stem cell transplantation as an approach to brain repair EXPERT OPINION ON THERAPEUTIC PATENTS. 2001 OCT; 11 (10): 1563-1582	2	5	32	252
1897	9922 Mattson MP, Chan SL Dysregulation of cellular calcium homeostasis in Alzheimer's disease - Bad genes and bad habits JOURNAL OF MOLECULAR NEUROSCIENCE. 2001 OCT; 17 (2): 205-224	19	79	32	185
1898	10537 Cole NB, Murphy DD, Grider T, Rueter S, Brasaemle D, et al. Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 FEB 22; 277 (8): 6344-6352	106	147	32	61
1899	10629 Buee-Scherrer V, Goedert M Phosphorylation of micro tubule-associated protein tau by stress- activated protein kinases in intact cells FEBS LETTERS. 2002 MAR 27; 515 (1-3): 151-154	18	38	32	44
1900	10854 Verpillat P, Camuzat A, Hannequin D, Thomas-Anterion C, Puel M, et al. Association between the extended tau haplotype and frontotemporal dementia ARCHIVES OF NEUROLOGY. 2002 JUN; 59 (6): 935-939	33	38	32	44

Date / Author / Journal

LCS

GCS

LCR

1801

14666 Tolnay M, Clavaguera F

Argyrophilic grain disease: A late-onset dementia with distinctive features among tauopathies

NEUROPATHOLOGY. 2004 DEC; 24 (4): 269-283

101

1802

14699 Lo Bianco C, Schneider BL, Bauer M, Sajadi A, Brice A, et al.

Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2004 DEC 14; 101 (50): 17510-17515

1803

14706 Kalia SK, Lee S, Smith PD, Liu L, Crocker SJ, et al.

BAG5 inhibits parkin and enhances dopaminergic neuron degeneration

NEURON. 2004 DEC 16; 44 (6): 931-945

1804

14794 Katsel PL, Davis KL, Haroutunian V

Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease

INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 63. 2005; 63: 41-82

228

1805

14931 Muchowski PJ, Wacker JL

Modulation of neurodegeneration by molecular chaperones

NATURE REVIEWS NEUROSCIENCE. 2005 JAN; 6 (1): 11-22

105

318

124

1806

14999 Liu F, Iqbal K, Grundke-Iqbal I, Rossie S, Gong CX

Dephosphorylation of tau by protein phosphatase 5 - Impairment in Alzheimer's disease

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 JAN 21; 280 (3): 1790-1796

1807

15096 Halverson RA, Lewis J, Frausto S, Hutton M, Muma NA

Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice

JOURNAL OF NEUROSCIENCE. 2005 FEB 2; 25 (5): 1226-1233

1808

15099 Pickhardt M, Gazova Z, von Bergen M, Khlistunova I, Wang YP, et al.

Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 FEB 4; 280 (5): 3628-3635

1809

15117 Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, et al.

P25 alpha stimulates a-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 FEB 18; 280 (7): 5703-5715

1810

15423 Mott RT, Dickson DW, Trojanowski JQ, Zhukareva V, Lee VMY, et al.

Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2005 MAY; 64 (5): 420-428

Date / Author / Journal

LCS

GCS

LCR

1811

15459 Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, et al.

A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease

NEUROLOGY. 2005 MAY 10; 64 (9): 1578-1585

1812

15724 Newman J, Rissman RA, Sarsoza F, Kim RC, Dick M, et al.

Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology

ACTA NEUROPATHOLOGICA. 2005 AUG; 110 (2): 135-144

1813

16663 Borlongan CV, Fournier C, Stahl CE, Yu GL, Xu L, et al.

Gene therapy, cell transplantation and stroke

FRONTIERS IN BIOSCIENCE. 2006 JAN 1; 11: 1090-U46

1814

16666 Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, et al.

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death

JOURNAL OF NEUROSCIENCE. 2006 JAN 4; 26 (1): 41-50

128

1815

17210 Balaraman Y, Limaye AR, Levey AI, Srinivasan S

Glycogen synthase kinase 3 beta and Alzheimer's disease: pathophysiological and therapeutic significance

CELLULAR AND MOLECULAR LIFE SCIENCES. 2006 JUN; 63 (11): 1226-1235

115

1816

17421 Ding HP, Matthews TA, Johnson GVW

Site-specific phosphorylation and caspase cleavage differentially impact tau-microtubule interactions and tau aggregation

JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 JUL 14; 281 (28): 19107-19114

1817

17821 Kontopoulos E, Parvin JD, Feany MB

alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

HUMAN MOLECULAR GENETICS. 2006 OCT 15; 15 (20): 3012-3023

1818

17879 Le Ber I, Guedj E, Gabelle A, Verpillat P, Volteau M, et al.

Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia

BRAIN. 2006 NOV; 129: 3051-3065

1819

18042 Takahashi M, Uchikado H, Caprotti D, Weidenheim KM, Dickson DW, et al.

Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2006 DEC; 65 (12): 1157-1169

1820

18165 Borsello T, Forloni G

JNK signalling: A possible target to prevent neurodegeneration

CURRENT PHARMACEUTICAL DESIGN. 2007; 13 (18): 1875-1886

120

Date / Author / Journal

LCS

GCS

LCR

1821

18480 Yasuda T, Miyachi S, Kitagawa R, Wada K, Nihira T, et al.

Neuronal specificity of alpha-synuclein toxicity and effect of parkin co-expression in primates

NEUROSCIENCE. 2007 JAN 19; 144 (2): 743-753

1822

18745 Schneider BL, Seehus CR, Capowski EE, Aebischer P, Zhang C, et al.

Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation

HUMAN MOLECULAR GENETICS. 2007 MAR 15; 16 (6): 651-666

1823

19669 Holm IE, Englund E, Mackenzie IRA, Johannsen P, Isaacs AM

A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2007 OCT; 66 (10): 884-891

1824

19915 Liu F, Li B, Tung EJ, Grundke-Iqbal I, Iqbal K, et al.

Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation

EUROPEAN JOURNAL OF NEUROSCIENCE. 2007 DEC; 26 (12): 3429-3436

1825

19921 Winklhofer KF

The parkin protein as a therapeutic target in Parkinson's disease

EXPERT OPINION ON THERAPEUTIC TARGETS. 2007 DEC; 11 (12): 1543-1552

1826

19996 Kimura T, Yamashita S, Fukuda T, Park JM, Murayama M, et al.

Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau

EMBO JOURNAL. 2007 DEC 12; 26 (24): 5143-5152

1827

20084 Mukaetova-Ladinska EB, Milne J, Andras A, Abdel-All Z, Cerejeira J, et al.

Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2008; 26 (1): 32-42

1828

20371 Sandal M, Valle F, Tessari I, Mammi S, Bergantino E, et al.

Conformational equilibria in monomeric alpha-synuclein at the single- molecule level

PLOS BIOLOGY. 2008 JAN; 6 (1): Art. No. e6

1829

20653 Soper JH, Roy S, Stieber A, Lee E, Wilson RB, et al.

alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae

MOLECULAR BIOLOGY OF THE CELL. 2008 MAR; 19 (3): 1093-1103

1830

20829 Wakamatsu M, Ishii A, Iwata S, Sakagami J, Ukai Y, et al.

Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice

NEUROBIOLOGY OF AGING. 2008 APR; 29 (4): 574-585

Date / Author / Journal

LCS

GCS

LCR

1831

20942 Richter-Landsberg C

The cytoskeleton in oligodendrocytes

JOURNAL OF MOLECULAR NEUROSCIENCE. 2008 MAY; 35 (1): 55-63

1832

20971 Klegeris A, Pelech S, Giasson BI, Maguire J, Zhang H, et al.

alpha-Synuclein activates stress signaling protein kinases in THP-1 cells and microglia

NEUROBIOLOGY OF AGING. 2008 MAY; 29 (5): 739-752

1833

21034 Chen-Plotkin AS, Geser F, Plotkin JB, Clark CM, Kwong LK, et al.

Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration

HUMAN MOLECULAR GENETICS. 2008 MAY 15; 17 (10): 1349-1362

1834

21479 Liu F, Hindupur J, Nguyen JL, Ruf KJ, Zhu J, et al.

Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults

FREE RADICAL BIOLOGY AND MEDICINE. 2008 AUG 1; 45 (3): 242-255

1835

21733 Brundin P, Li JY, Holton JL, Lindvall O, Revesz T

Research in motion: the enigma of Parkinson's disease pathology spread

NATURE REVIEWS NEUROSCIENCE. 2008 OCT; 9 (10): 741-745

1836

21756 Caudle WM, Pan S, Shi M, Quinn T, Hoekstra J, et al.

Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease

PROTEOMICS CLINICAL APPLICATIONS. 2008 OCT; 2 (10-11): 1484-1497

122

1837

21785 Ittner LM, Fath T, Ke YD, Bi M, van Eersel J, et al.

Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2008 OCT 14; 105 (41): 15997-16002

1838

22178 Watson R, Blamire AM, O'Brien JT

Magnetic Resonance Imaging in Lewy Body Dementias

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS. 2009; 28 (6): 493-506

1839

22220 Morcos M, Hutter H

The Model Caenorhabditis elegans in Diabetes Mellitus and Alzheimer's Disease

JOURNAL OF ALZHEIMERS DISEASE. 2009; 16 (4): 897-908

142

1840

22660 Lambert MP, Velasco PT, Viola KL, Klein WL

Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid beta-Derived Neurotoxins

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2009 MAR; 8 (1): 65-81

122

Date / Author / Journal

LCS

GCS

LCR

1841

22687 Yu Y, Run XQ, Liang ZH, Li Y, Liu F, et al.

Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases

JOURNAL OF NEUROCHEMISTRY. 2009 MAR; 108 (6): 1480-1494

1842

22996 Diehl-Schmid J, Neumann M, Laws SM, Perneczky R, Grimmer T, et al.

Frontotemporal Lobar Degeneration Part 2: Neuroimaging, Neuropathology, Neurogenetics

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE. 2009 MAY; 77 (5): 295-301

1843

23192 Saiki S, Hattori N

Molecular Genetics and Pathogenesis of Parkinson Disease

NEUROLOGICAL SURGERY. 2009 JUN; 37 (6): 531-541

1844

23289 Liu F, Shi JH, Tanimukai H, Gu JH, Gu JL, et al.

Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease

BRAIN. 2009 JUL; 132: 1820-1832

1845

23429 Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, et al.

TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity

JOURNAL OF BIOLOGICAL CHEMISTRY. 2009 JUL 24; 284 (30): 20329-20339

1846

23489 Planel E, Bretteville A, Liu L, Virag L, Du AL, et al.

Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia

FASEB JOURNAL. 2009 AUG; 23 (8): 2595-2604

1847

23730 Lendel C, Bertoncini CW, Cremades N, Waudby CA, Vendruscolo M, et al.

On the Mechanism of Nonspecific Inhibitors of Protein Aggregation: Dissecting the Interactions of alpha-Synuclein with Congo Red and Lacmoid

BIOCHEMISTRY. 2009 SEP 8; 48 (35): 8322-8334

1848

23844 Shah SB, Nolan R, Davis E, Stokin GB, Niesman I, et al.

Examination of potential mechanisms of amyloid-induced defects in neuronal transport

NEUROBIOLOGY OF DISEASE. 2009 OCT; 36 (1): 11-25

111

1849

23906 Uno Y, Iwashita H, Tsukamoto T, Uchiyama N, Kawamoto T, et al.

Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3- (1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3- carboxamide in tau transgenic mice

BRAIN RESEARCH. 2009 OCT 16; 1296: 148-163

1850

23907 Moisse K, Mepham J, Volkening K, Welch I, Hill T, et al.

Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL-/- mice: Support for a role for TDP-43 in the physiological response to neuronal injury

BRAIN RESEARCH. 2009 OCT 16; 1296: 176-186

Date / Author / Journal

LCS

GCS

LCR

1851

23911 Karpinar DP, Balija MBG, Kugler S, Opazo F, Rezaei-Ghaleh N, et al.

Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models

EMBO JOURNAL. 2009 OCT 21; 28 (20): 3256-3268

1852

23923 Vickers JC, King AE, Woodhouse A, Kirkcaldie MT, Staal JA, et al.

Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system

BRAIN RESEARCH BULLETIN. 2009 OCT 28; 80 (4-5): 217-223

105

1853

23938 Munoz DG, Neumann M, Kusaka H, Yokota O, Ishihara K, et al.

FUS pathology in basophilic inclusion body disease

ACTA NEUROPATHOLOGICA. 2009 NOV; 118 (5): 617-627

1854

23968 Phillips RJ, Walter GC, Ringer BE, Higgs KM, Powley TL

Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat

EXPERIMENTAL NEUROLOGY. 2009 NOV; 220 (1): 109-119

1855

24147 Schlachetzki JCM, Schmidtke K, Beckervordersandforth J, Borozdin W, Wilhelm C, et al.

Frequency of progranulin mutations in a German cohort of 79 frontotemporal dementia patients

JOURNAL OF NEUROLOGY. 2009 DEC; 256 (12): 2043-2051

1856

24464 Fahn S

Parkinson's Disease: 10 Years of Progress, 1997-2007

MOVEMENT DISORDERS. 2010; 25 (3): S2-S14

145

1857

24724 Drzezga A

Amyloid-plaque imaging in early and differential diagnosis of dementia

ANNALS OF NUCLEAR MEDICINE. 2010 FEB; 24 (2): 55-66

1858

24728 Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, et al.

The Spectrum of Mutations in Progranulin A Collaborative Study Screening 545 Cases of Neurodegeneration

ARCHIVES OF NEUROLOGY. 2010 FEB; 67 (2): 161-170

1859

24800 Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, et al.

Phosphorylation of Tau at S422 is enhanced by A beta in TauPS2APP triple transgenic mice

NEUROBIOLOGY OF DISEASE. 2010 FEB; 37 (2): 294-306

1860

24842 Yang ML, Hasadsri L, Woods WS, George JM

Dynamic transport and localization of alpha-synuclein in primary hippocampal neurons

MOLECULAR NEURODEGENERATION. 2010 FEB 9; 5: Art. No. 9

Date / Author / Journal

LCS

GCS

LCR

1861

24871 Latawiec D, Herrera F, Bek A, Losasso V, Candotti M, et al.

Modulation of Alpha-Synuclein Aggregation by Dopamine Analogs

PLOS ONE. 2010 FEB 16; 5 (2): Art. No. e9234

1862

24882 Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, et al.

TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010 FEB 23; 107 (8): 3858-3863

1863

25153 Lauterbach EC, Shillcutt SD, Victoroff J, Coburn KL, Mendez MF

Psychopharmacological Neuroprotection in Neurodegenerative Disease: Heuristic Clinical Applications

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES. 2010 SPR; 22 (2): 130-154

467

1864

25388 Iijima-Ando K, Zhao LJ, Gatt A, Shenton C, Iijima K

A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration

HUMAN MOLECULAR GENETICS. 2010 MAY 15; 19 (10): 1930-1938

1865

25492 Eckert A, Schulz KL, Rhein V, Gotz J

Convergence of Amyloid-beta and Tau Pathologies on Mitochondria In Vivo

MOLECULAR NEUROBIOLOGY. 2010 JUN; 41 (2-3): 107-114

1866

25577 Yokota O, Davidson Y, Bigio EH, Ishizu H, Terada S, et al.

Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy

ACTA NEUROPATHOLOGICA. 2010 JUL; 120 (1): 55-66

1867

25613 Schmidt AL, Brunetto AL, Schwartsmann G, Roesler R, Abujamra AL

Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. 2010 JUL; 9 (3): 335-348

179

1868

25674 Khurana V, Elson-Schwab I, Fulga TA, Sharp KA, Loewen CA, et al.

Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo

PLOS GENETICS. 2010 JUL; 6 (7): Art. No. e1001026

1869

25759 Brion JP, Ando K, Heraud C, Leroy K

Modulation of tau pathology in tau transgenic models

BIOCHEMICAL SOCIETY TRANSACTIONS. 2010 AUG; 38: 996-1000

1870

26390 Kleinberger G, Wils H, Ponsaerts P, Joris G, Timmermans JP, et al.

Increased caspase activation and decreased TDP-43 solubility in progranulin knockout cortical cultures

JOURNAL OF NEUROCHEMISTRY. 2010 NOV; 115 (3): 735-747

Date / Author / Journal

LCS

GCS

LCR

1871

26395 Hellewell SC, Yan EB, Agyapomaa DA, Bye N, Morganti-Kossmann MC

Post-Traumatic Hypoxia Exacerbates Brain Tissue Damage: Analysis of Axonal Injury and Glial Responses

JOURNAL OF NEUROTRAUMA. 2010 NOV; 27 (11): 1997-2010

102

1872

26682 Forlenza OV, Diniz BS, Gattaz WF

Diagnosis and biomarkers of predementia in Alzheimer's disease

BMC MEDICINE. 2010 DEC 22; 8: Art. No. 89

113

1873

26692 Yang CX, Tan WJ, Whittle C, Qiu LH, Cao LC, et al.

The C-Terminal TDP-43 Fragments Have a High Aggregation Propensity and Harm Neurons by a Dominant-Negative Mechanism

PLOS ONE. 2010 DEC 31; 5 (12): Art. No. e15878

1874

26710 Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P

Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis

ACTA NEUROPATHOLOGICA. 2011 JAN; 121 (1): 21-37

167

1875

26868 Scales TME, Derkinderen P, Leung KY, Byers HL, Ward MA, et al.

Tyrosine Phosphorylation of Tau by the Src Family Kinases Lck and Fyn

MOLECULAR NEURODEGENERATION. 2011 JAN 26; 6: Art. No. 12

1876

26909 Armstrong RA, Cairns NJ

A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation

HISTOLOGY AND HISTOPATHOLOGY. 2011 FEB; 26 (2): 185-190

1877

1837 YETERIAN EH, PANDYA DN

CORTICOTHALAMIC CONNECTIONS OF THE SUPERIOR TEMPORAL SULCUS IN RHESUS- MONKEYS

EXPERIMENTAL BRAIN RESEARCH. 1991; 83 (2): 268-284

120

1878

3322 GOEDERT M, JAKES R, CROWTHER RA, COHEN P, VANMECHELEN E, et al.

EPITOPE MAPPING OF MONOCLONAL-ANTIBODIES TO THE PAIRED HELICAL FILAMENTS OF ALZHEIMERS-DISEASE - IDENTIFICATION OF PHOSPHORYLATION SITES IN TAU-PROTEIN

BIOCHEMICAL JOURNAL. 1994 AUG 1; 301: 871-877

188

224

1879

3613 SONG JS, YANG SD

TAU-PROTEIN KINASE-I GSK-3-BETA KINASE F-A IN HEPARIN PHOSPHORYLATES TAU ON SER(199), THR(231), SER(235), SER(262) SER(369), AND SER(400) SITES PHOSPHORYLATED IN ALZHEIMER-DISEASE BRAIN

JOURNAL OF PROTEIN CHEMISTRY. 1995 FEB; 14 (2): 95-105

1880

3732 GOTZ J, PROBST A, SPILLANTINI MG, SCHAFER T, JAKES R, et al.

SOMATODENDRITIC LOCALIZATION AND HYPERPHOSPHORYLATION OF TAU-PROTEIN IN TRANSGENIC MICE EXPRESSING THE LONGEST HUMAN BRAIN TAU-ISOFORM

EMBO JOURNAL. 1995 APR 3; 14 (7): 1304-1313

160

183

Date / Author / Journal

LCS

GCS

LCR

1881

3814 LATIMER DA, GALLO JM, LOVESTONE S, MILLER CCJ, REYNOLDS CH, et al.

STIMULATION OF MAP KINASE BY V-RAF TRANSFORMATION OF FIBROBLASTS FAILS TO INDUCE HYPERPHOSPHORYLATION OF TRANSFECTED TAU

FEBS LETTERS. 1995 MAY 22; 365 (1): 42-46

1882

4083 MukaetovaLadinska EB, Roth M

Alzheimer's disease - New approaches to old problems

INTERNATIONAL REVIEW OF PSYCHIATRY. 1995 DEC; 7 (3-4): 419-435

156

1883

4783 Shin RW

Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease

GERONTOLOGY. 1997; 43: 16-23

1884

5158 Reynolds CH, Nebreda AR, Gibb GM, Utton MA, Anderton BH

Reactivating kinase/p38 phosphorylates tau protein in vitro

JOURNAL OF NEUROCHEMISTRY. 1997 JUL; 69 (1): 191-198

1885

5539 Giasson BI, Mushynski WE

Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit

JOURNAL OF NEUROSCIENCE. 1997 DEC 15; 17 (24): 9466-9472

1886

6614 Goedert M, Crowther RA, Jakes R, Hasegawa M, Smith MJ, et al.

Filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases

ALZHEIMER'S DISEASE AND RELATED DISORDERS. 1999; : 245-258

1887

7136 Matsumura N, Yamazaki T, Ihara Y

Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17)

AMERICAN JOURNAL OF PATHOLOGY. 1999 JUN; 154 (6): 1649-1656

1888

7475 Dickson DW, Lin WL, Liu WK, Yen SH

Multiple system atrophy: A sporadic synucleinopathy

BRAIN PATHOLOGY. 1999 OCT; 9 (4): 721-732

1889

7593 Lippa CF

Familial Alzheimer's disease: Genetic influences on the disease process (Review)

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 1999 NOV; 4 (5): 529-536

106

1890

8230 Alexi T, Borlongan CV, Faull RLM, Williams CE, Clark RG, et al.

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases

PROGRESS IN NEUROBIOLOGY. 2000 APR; 60 (5): 409-470

140

724

Date / Author / Journal

LCS

GCS

LCR

1891

8583 Evans DB, Rank KB, Bhattacharya K, Thomsen DR, Gurney ME, et al.

Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly

JOURNAL OF BIOLOGICAL CHEMISTRY. 2000 AUG 11; 275 (32): 24977-24983

1892

9405 Lee FJS, Liu F, Pristupa ZB, Niznik HB

Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis

FASEB JOURNAL. 2001 APR; 15 (6): 916-926

133

200

1893

9757 McNaught KSP, Olanow CW, Halliwell B, Isacson O, Jenner P

Failure of the ubiquitin-proteasome system in Parkinson's disease

NATURE REVIEWS NEUROSCIENCE. 2001 AUG; 2 (8): 589-594

110

237

1894

9790 Wirdefeldt K, Bogdanovic N, Westerberg L, Payami H, Schalling M, et al.

Expression of alpha-synuclein in the human brain: relation to Lewy body disease

MOLECULAR BRAIN RESEARCH. 2001 AUG 15; 92 (1-2): 58-65

1895

9874 Rockenstein E, Hansen LA, Mallory M, Trojanowski JQ, Galasko D, et al.

Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease

BRAIN RESEARCH. 2001 SEP 28; 914 (1-2): 48-56

1896

9907 Armstrong RJE, Jain M, Barker RA

Stem cell transplantation as an approach to brain repair

EXPERT OPINION ON THERAPEUTIC PATENTS. 2001 OCT; 11 (10): 1563-1582

252

1897

9922 Mattson MP, Chan SL

Dysregulation of cellular calcium homeostasis in Alzheimer's disease - Bad genes and bad habits

JOURNAL OF MOLECULAR NEUROSCIENCE. 2001 OCT; 17 (2): 205-224

185

1898

10537 Cole NB, Murphy DD, Grider T, Rueter S, Brasaemle D, et al.

Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein

JOURNAL OF BIOLOGICAL CHEMISTRY. 2002 FEB 22; 277 (8): 6344-6352

106

147

1899

10629 Buee-Scherrer V, Goedert M

Phosphorylation of micro tubule-associated protein tau by stress- activated protein kinases in intact cells

FEBS LETTERS. 2002 MAR 27; 515 (1-3): 151-154

1900

10854 Verpillat P, Camuzat A, Hannequin D, Thomas-Anterion C, Puel M, et al.

Association between the extended tau haplotype and frontotemporal dementia

ARCHIVES OF NEUROLOGY. 2002 JUN; 59 (6): 935-939

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records